Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Jim Cramer's top picks for pet-centric stocks
Tags stocks Investing THE JM SMUCKDRN
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Novo Nordisk A/S Biotechnology China Economy
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Biotech and Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Business US: News Companies
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Novo Nordisk A/S Eli Lilly and Co Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Labor economy Social issues Healthy Returns
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags CNBC Changemakers Business News Alphabet Inc
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Investment Strategy Business U/S/ Markets
From CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
Tags Business News Health care industry Biotechnology
From CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
Tickers RH
Tags Investment Strategy Business RH
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Pfizer Inc Health care industry Bristol/Myers Squibb Co
From CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
Tags Technology Pharmaceuticals Alphabet Inc
From CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
Tags Eli Lilly and Co Alphabet Inc Breaking News: Technology
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Health Insurance Small Business Playbook Eli Lilly and Co
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Business US: News Companies
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags U/S/ Markets Finance Amgen Inc
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Goldman Sachs Group Inc Teladoc Health Inc Health & Science
From CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
Tags Business News Companies Business
From CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
Tags Investment strategy Mad Money Business News
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Fusion Pharmaceuticals Inc Biotech and Pharmaceuticals Novartis AG
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Biotech and Pharmaceuticals Health & Science Science
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Business News Novo Nordisk A/S Biotechnology
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Healthy Returns Social issues Health care industry
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags US: News Business Social issues
From CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
Tags Breaking News: Technology Technology Tesla Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Health & Science Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags AstraZeneca PLC Eli Lilly and Co Altimmune Inc
From CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
Tags Eli Lilly and Co Drugs Pharmaceuticals
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Pharmaceuticals Health care industry Biotechnology
From CNBC.com News
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
Tags LVMH Moet Hennessy Louis Vuitton SE Europe News Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.